Question 1

Has Paul Lapoint received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,568 in general payments to Paul Lapoint across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Paul Lapoint did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Paul Lapoint come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie	17	$264
Therapeuticsmd, Inc.	15	$213
Pfizer	13	$134
Bayer	7	$120
Merck	4	$118
Lupin Inc.	8	$103
Amgen	5	$100
Cumberland Pharmaceuticals, Inc.	4	$50
Johnson & Johnson	2	$48
AMAG Pharmaceuticals, Inc.	2	$40
Evofem Biosciences, Inc.	2	$38
Astellas Pharma US Inc	2	$37
Myovant Sciences Inc.	2	$36
Daiichi Sankyo Inc.	2	$33
Covidien LP	2	$33
Hologic Sales And Service, LLC	2	$31
Duchesnay USA Incorporated	2	$30
Aesculap, Inc.	2	$29
Exeltis, USA Inc.	2	$27
Mayne Pharma Commercial LLC	1	$17
Gilead	1	$15
Agile Therapeutics, Inc.	1	$14
Sage Therapeutics, LLC	1	$14
Boston Scientific	1	$13
Smith+Nephew	1	$11

Paul Lapoint

Payments from drug & device makers

Who reported the general payments

How this compares

Other obstetrics & gynecology in Chesterfield